Plasma phosphorylated tau 181 predicts amyloid status and conversion to dementia stage dependent on renal function

OBJECTIVES: Plasma P-tau181 is an increasingly established diagnostic marker for Alzheimer’s disease (AD). Further validation in prospective cohorts is still needed, as well as the study of confounding factors that could influence its blood level. METHODS: This study is ancillary to the prospective...

Descripción completa

Detalles Bibliográficos
Autores principales: Lehmann, Sylvain, Schraen-Maschke, Susanna, Vidal, Jean-Sébastien, Delaby, Constance, Blanc, Frédéric, Paquet, Claire, Allinquant, Bernadette, Bombois, Stéphanie, Gabelle, Audrey, Hanon, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Neurodegeneration
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314000/
https://www.ncbi.nlm.nih.gov/pubmed/37012068
http://dx.doi.org/10.1136/jnnp-2022-330540

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314000/
https://www.ncbi.nlm.nih.gov/pubmed/37012068
http://dx.doi.org/10.1136/jnnp-2022-330540

Ejemplares similares